Patent · US Active

Substituted quinazoline compounds and their use in treating angiogenesis-related diseases

US7829574B2 · kind B2 · utility

1Cited by

3References

17Claims

0Family size

Assignee

Hutchison MediPharma Enterprises Limited · BS

Inventors

Wei-Guo Su · Shanghai, CN
Weihan Zhang · Shanghai, CN
Xiaoqiang Yan · Shanghai, CN
Yumin Cui · Shanghai, CN
Yongxin Ren · Shanghai, CN
Jifeng Duan · Shanghai, CN

Key dates

Filing date	May 9, 2008
Grant date	Nov 9, 2010
Priority date	—
Expiry date	May 9, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Substituted quinazoline compounds of the following formula:wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, and X are defined herein. It also discloses a pharmaceutical composition containing one of these compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.